Biotechnology
Jobs at Arrowhead Pharmaceuticals
About Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
- Industry
- Biotechnology
- Open roles
- 91
Open positions
Explore roles at Arrowhead Pharmaceuticals
Showing 50 of 91 roles
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapeutics targeting intractable diseases.